Trials / Completed
CompletedNCT03879434
Routine Application of Ostenil® Mini in Patients with Rhizarthrosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (actual)
- Sponsor
- TRB Chemedica AG · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
PMCF study to observe the routine application of Ostenil® Mini in the treatment of pain and restricted mobility in degenerative and traumatic changes of the CMC joint.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ostenil® Mini | Ostenil® Mini is a CE-certified viscoelastic solution for injection into the Joint cavity, containing 1.0 % sodium hyaluronate from fermentation |
Timeline
- Start date
- 2019-04-17
- Primary completion
- 2024-05-16
- Completion
- 2024-05-16
- First posted
- 2019-03-18
- Last updated
- 2024-10-09
Locations
6 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT03879434. Inclusion in this directory is not an endorsement.